ENCORE HEALTH LLC has a total of 31 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2004. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are BIOVISTA INC, RADIORX INC and ACTIVBIOTICS PHARMA LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Hong Kong | 2 | |
#5 | Japan | 2 | |
#6 | Australia | 1 | |
#7 | Canada | 1 | |
#8 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Electrotherapy | |
#5 | Implantable devices |
# | Name | Total Patents |
---|---|---|
#1 | Garner Margaret | 23 |
#2 | Garner William | 22 |
#3 | Minno George | 15 |
#4 | Gooden David | 15 |
#5 | Till Jonathan S | 7 |
#6 | Blum Ronald D | 7 |
#7 | Burns William R | 1 |
#8 | Duston Dwight P | 1 |
#9 | Kokonaski William | 1 |
#10 | Garner Willliam | 1 |
Publication | Filing date | Title |
---|---|---|
EP3542629A2 | Dithiol compounds, derivatives, and uses therefor | |
EP2442645A1 | Choline esters | |
EP2364084A1 | Low dose lipoic acid pharmaceutical compositions and methods | |
WO2009111635A2 | Dithiol compounds, derivatives, and uses therefor | |
WO2008067403A2 | Presbyopia treatment by lens alteration | |
AU2005300005A1 | Presbyopia treatment by lens alteration | |
US2005287201A1 | Method for delivery of pharmaceuticals for treating or preventing presbyopia | |
US2005101677A1 | Presbyopia treatment by lens alteration |